medroxyprogesterone acetate has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnusdei, V; Basso, G; Bortolozzi, R; Boso, D; Bresolin, S; Cazzaniga, G; Mariotto, E; Maule, F; Minuzzo, S; Paganin, M; Persano, L; Rampazzo, E; Te Kronnie, G; Viola, G | 1 |
1 other study(ies) available for medroxyprogesterone acetate and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
AKR1C enzymes sustain therapy resistance in paediatric T-ALL.
Topics: 20-Hydroxysteroid Dehydrogenases; Age of Onset; Aldo-Keto Reductase Family 1 Member C3; Aldo-Keto Reductases; Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; Hydroxysteroid Dehydrogenases; Isoenzymes; Medroxyprogesterone Acetate; Mice; Mice, Inbred NOD; Mice, SCID; Oxidoreductases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vincristine; Xenograft Model Antitumor Assays | 2018 |